Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Europe Molecular Diagnostics Market Forecast 2028 By Application (Infectious Disease Diagnostics {COVID-19, HIV, CT/NG, Hepatitis B, Hepatitis C, RSV, Flu, Tuberculosis}, Oncology Testing, Genetic Disease Testing), By Technology (Polymerase Chain Reaction [PCR], Hybridization, Sequencing, Isothermal Nucleic Acid Amplification Technology [INAAT], Microarrays), By Product (Instruments, Reagents & Kits), By End-use (Diagnostics Laboratories, Hospitals & Clinics), Research Report, Country Outlook (Germany, UK, France, Spain, Portugal, Italy, Russia, Denmark, Norway, Sweden), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: August 2022   |   Report ID: GR1142   |   Delivery: PDF  Request Free Sample

    Europe Molecular Diagnostics Market size surpassed USD 18.04 billion in 2021 and is slated to witness -6% CAGR between 2022 and 2028. The market demand is driven by the growing burden of chronic disorders and the availability of favorable reimbursement scenarios.

    Impact of COVID-19 on the European Market

    As the coronavirus rapidly spreads worldwide, precise molecular diagnostic tools are becoming increasingly crucial in managing the life-threatening disease. In keeping with this, in September 2021, the EU and WHO established a molecular diagnostic laboratory in Wau, South Sudan to increase the testing capacity for COVID-19 and other infectious diseases.

    Europe Market, By Technology

    To enable the accurate diagnosis of diseases, several technologically advanced PCR devices are being developed. As a result, the PCR technology segment will observe decent growth till 2028, driven by the innovation of research and medical diagnostic technologies, along with the rapid deployment of automatic solutions such as robotics.

    Europe Market, By Application

    The oncology testing segment will cross USD 980 million revenue by 2028, due to the introduction of advanced cancer diagnostic tests by prominent companies. For example, in March 2022, Illumina launched an in-vitro diagnostic test designed to profile cancer mutations and direct patients to targeted therapies in Europe.

    Europe Market, By End-use

    The diagnostic laboratories segment will observe significant gains during the forecast period, driven by the growing reliance on lab test results for making medical decisions. In addition, the potential rise in investments to digitize diagnostic care will transform the way of sharing test results and images across labs.

    Europe Market, By Country

    Germany molecular diagnostics market size will dominate the revenue share through 2028, given the rising prevalence of major lifestyle diseases such as heart disease. There have been rapid discoveries in the field of human genetics and molecular biology. These rapidly evolving techniques are further supported by innovative approaches in technology, further enabling the country to serve as a prominent market for molecular diagnostic test developers.

    Competitive Industry Landscape

    Prominent participants operating across the market include Roche Diagnostics, GenMark, Johnson & Johnson, Danaher, Cephied, BioRad Laboratories, Biomerieux, Becton Dickinson, Analytik Jena, Alere, Agilent (Dako), Abbott Molecular. These companies are targeting to gain a competitive advantage and expand their regional footprint through innovative product launches and other strategies.

    Frequently Asked Question(FAQ) :

    What was the worth of Europe molecular diagnostics market in 2021?
    The industry for molecular diagnostics in Europe as valued at around USD 18,040 million in 2021 and is forecast to exhibit a CAGR of -6% between 2022 and 2028.
    Why is the application scope of the Europe molecular diagnostics industry from the oncology testing segment increasing?
    The oncology testing segment will be valued at nearly USD 980 million by 2028, owing to the rising emphasis on the development of advanced cancer diagnostic tests.
    Which country will serve as a major hub for the Europe molecular diagnostics sector participants?
    The industry for molecular diagnostics in Germany will hold a decent revenue share by 2028, which can be credited to the high prevalence of lifestyle diseases.
    Who provides molecular diagnostics in Europe?
    Major companies partaking in the market share include Roche Diagnostics, GenMark, Johnson & Johnson, Danaher, Cephied, BioRad Laboratories, Biomerieux, Becton Dickinson, Analytik Jena, Alere, Agilent (Dako), and Abbott Molecular, among others.

    Get this research report on Europe Molecular Diagnostics Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]